Isolated limb perfusion for melanoma

This publication has 11 references indexed in Scilit:

• Isolated limb perfusion with tumour necrosis factor-α and melphalan with or without interferon-γ; for the treatment of in-transit melanoma metastases
  Melanoma Research, 1999
• Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
  Journal of Clinical Oncology, 1998
• Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusion
  Seminars in Surgical Oncology, 1998
• Thirty-five years of isolated limb perfusion for melanoma: Indications and results
  British Journal of Surgery, 1996
• A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities
  European Journal Of Cancer, 1995
• Results of regional isolated perfusion for locally inoperable melanoma of the limbs
  Melanoma Research, 1994
• Systemic leakage during isolated limb perfusion for melanoma
  British Journal of Surgery, 1993
• A retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with melphalan in patients with recurrent melanoma of the lower limb
  Cancer, 1993
• High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
  Journal of Clinical Oncology, 1992
• Chemotherapy of Cancer
  Annals of Surgery, 1958